# 108 BioCapital

Investor in Danbury, Connecticut

## About 108 BioCapital

108 BioCapital is a U.S.-based private equity firm focused on growth-stage investments in biotech and medtech companies developing scalable, exit-driven solutions that address high-impact unmet medical needs. We invest in businesses with clear and accelerated regulatory pathways, validated clinical or technical foundations, and a line of sight to meaningful commercial adoption.

At 108 BioCapital, we are dedicated to advancing the frontiers of medical innovation. Our mission is to invest in transformative healthcare solutions that address urgent unmet medical needs, improve patient outcomes, and deliver sustained value to our investors.

The US healthcare and medtech sectors present an extraordinary growth opportunity, with healthcare spending projected to reach 20% of GDP by 2032.

Advances in diagnostics, therapeutic devices, and personalized medicine are reshaping the industry. We seek to partner with visionary entrepreneurs and management teams, leveraging our expertise and network to accelerate growth and maximize impact.

## People

- **Sasha Bakhru**, Founder & CEO

## Key Facts

- **Location:** Danbury, Connecticut
- **Investor Type:** Private Equity
- **Founded:** 2025

## Investment Industries

- Biotech
- Medical/Healthcare

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/108-biocapital
- More investors: [Biotech Investors in Connecticut](https://askforfunding.com/site/angel-investors/connecticut/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
